Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2365)
All Articles published online
|
Jan 7, 2007 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kann M, Schmitz A, Rabe B. Intracellular transport of hepatitis B virus. World J Gastroenterol 2007; 13(1): 39-47 [PMID: 17206753 DOI: 10.3748/wjg.v13.i1.39] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i1/39.htm |
| Number | Citing Articles |
| 1 |
K. Weigand, A. Knaust, H. Schaller. Assembly and export determine the intracellular distribution of hepatitis B virus core protein subunits. Journal of General Virology 2010; 91(1): 59 doi: 10.1099/vir.0.013698-0
|
| 2 |
Dawei Cai, Courtney Mills, Wenquan Yu, Ran Yan, Carol E. Aldrich, Jeffry R. Saputelli, William S. Mason, Xiaodong Xu, Ju-Tao Guo, Timothy M. Block, Andrea Cuconati, Haitao Guo. Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation. Antimicrobial Agents and Chemotherapy 2012; 56(8): 4277 doi: 10.1128/AAC.00473-12
|
| 3 |
Wataru Kinoshita, Naoki Ogura, Koichi Watashi, Takaji Wakita. Host factor PRPF31 is involved in cccDNA production in HBV-replicating cells. Biochemical and Biophysical Research Communications 2017; 482(4): 638 doi: 10.1016/j.bbrc.2016.11.085
|
| 4 |
Chao Chen, Joseph Che-Yen Wang, Elizabeth E. Pierson, David Z. Keifer, Mildred Delaleau, Lara Gallucci, Christian Cazenave, Michael Kann, Martin F. Jarrold, Adam Zlotnick, Jianming Hu. Importin β Can Bind Hepatitis B Virus Core Protein and Empty Core-Like Particles and Induce Structural Changes. PLOS Pathogens 2016; 12(8): e1005802 doi: 10.1371/journal.ppat.1005802
|
| 5 |
P. Pumpens, E. Grens. The true story and advantages of the famous Hepatitis B virus core particles: Outlook 2016. Molecular Biology 2016; 50(4): 489 doi: 10.1134/S0026893316040099
|
| 6 |
Christopher John Schlicksup, Joseph Che-Yen Wang, Samson Francis, Balasubramanian Venkatakrishnan, William W Turner, Michael VanNieuwenhze, Adam Zlotnick. Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids. eLife 2018; 7 doi: 10.7554/eLife.31473
|
| 7 |
Timothy M. Block, Haitao Guo, Ju-Tao Guo. Molecular Virology of Hepatitis B Virus for Clinicians. Clinics in Liver Disease 2007; 11(4): 685 doi: 10.1016/j.cld.2007.08.002
|
| 8 |
Dejuan Sun, Lingjuan Zhu, Dahong Yao, Lixia Chen, Leilei Fu, Liang Ouyang. Recent progress in potential anti-hepatitis B virus agents: Structural and pharmacological perspectives. European Journal of Medicinal Chemistry 2018; 147: 205 doi: 10.1016/j.ejmech.2018.02.001
|
| 9 |
Hye Won Lee, Jae Seung Lee, Sang Hoon Ahn. Hepatitis B Virus Cure: Targets and Future Therapies. International Journal of Molecular Sciences 2020; 22(1): 213 doi: 10.3390/ijms22010213
|
| 10 |
Josef Köck, Christine Rösler, Jing-Jing Zhang, Hubert E. Blum, Michael Nassal, Christian Thoma, Jing-hsiung James Ou. Generation of Covalently Closed Circular DNA of Hepatitis B Viruses via Intracellular Recycling Is Regulated in a Virus Specific Manner. PLoS Pathogens 2010; 6(9): e1001082 doi: 10.1371/journal.ppat.1001082
|
| 11 |
Justin W. Flatt, Urs F. Greber. Viral mechanisms for docking and delivering at nuclear pore complexes. Seminars in Cell & Developmental Biology 2017; 68: 59 doi: 10.1016/j.semcdb.2017.05.008
|
| 12 |
Haitao Guo, Richeng Mao, Timothy M. Block, Ju-Tao Guo. Production and Function of the Cytoplasmic Deproteinized Relaxed Circular DNA of Hepadnaviruses. Journal of Virology 2010; 84(1): 387 doi: 10.1128/JVI.01921-09
|
| 13 |
Xiuji Cui, Laurie Ludgate, Xiaojun Ning, Jianming Hu. Maturation-Associated Destabilization of Hepatitis B Virus Nucleocapsid. Journal of Virology 2013; 87(21): 11494 doi: 10.1128/JVI.01912-13
|
| 14 |
Michael Nassal. Hepatitis B viruses: Reverse transcription a different way. Virus Research 2008; 134(1-2): 235 doi: 10.1016/j.virusres.2007.12.024
|
| 15 |
Jieliang Chen, Min Wu, Kuancheng Liu, Wen Zhang, Yaming Li, Xiaohui Zhou, Lu Bai, Zhenghong Yuan. New insights into hepatitis B virus biology and implications for novel antiviral strategies. National Science Review 2015; 2(3): 296 doi: 10.1093/nsr/nwv044
|
| 16 |
Christopher John Schlicksup, Patrick Laughlin, Steven Dunkelbarger, Joseph Che-Yen Wang, Adam Zlotnick. Local Stabilization of Subunit–Subunit Contacts Causes Global Destabilization of Hepatitis B Virus Capsids. ACS Chemical Biology 2020; 15(6): 1708 doi: 10.1021/acschembio.0c00320
|
| 17 |
Jehoon Kim, Jianzhong Wu. A Theoretical Study of SRPK Interaction with the Flexible Domains of Hepatitis B Capsids. Biophysical Journal 2014; 107(6): 1453 doi: 10.1016/j.bpj.2014.07.032
|
| 18 |
|
| 19 |
Dong Meng, Rex P Hjelm, Jianming Hu, Jianzhong Wu. A Theoretical Model for the Dynamic Structure of Hepatitis B Nucleocapsid. Biophysical Journal 2011; 101(10): 2476 doi: 10.1016/j.bpj.2011.10.002
|
| 20 |
Dai Kurihara, Hidetaka Akita, Asako Kudo, Tomoya Masuda, Shiroh Futaki, Hideyoshi Harashima. Effect of Polyethyleneglycol Spacer on the Binding Properties of Nuclear Localization Signal-Modified Liposomes to Isolated Nucleus. Biological and Pharmaceutical Bulletin 2009; 32(7): 1303 doi: 10.1248/bpb.32.1303
|
| 21 |
Lei Wei, Alexander Ploss. Mechanism of Hepatitis B Virus cccDNA Formation. Viruses 2021; 13(8): 1463 doi: 10.3390/v13081463
|
| 22 |
Balasubramanian Venkatakrishnan, Adam Zlotnick. The Structural Biology of Hepatitis B Virus: Form and Function. Annual Review of Virology 2016; 3(1): 429 doi: 10.1146/annurev-virology-110615-042238
|
| 23 |
Fabien Abdul, Bénédicte Ndeboko, Thierry Buronfosse, Fabien Zoulim, Michael Kann, Peter E. Nielsen, Lucyna Cova, Wang-Shick Ryu. Potent Inhibition of Late Stages of Hepadnavirus Replication by a Modified Cell Penetrating Peptide. PLoS ONE 2012; 7(11): e48721 doi: 10.1371/journal.pone.0048721
|
| 24 |
Gang Wang, Jun Guan, Nazif U. Khan, Guojun Li, Junwei Shao, Qihui Zhou, Lichen Xu, Chunhong Huang, Jingwen Deng, Haihong Zhu, Zhi Chen. Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00421-9
|
| 25 |
Gaëtan Ligat, Eloi R Verrier, Michael Nassal, Thomas F Baumert. Hepatitis B virus–host interactions and novel targets for viral cure. Current Opinion in Virology 2021; 49: 41 doi: 10.1016/j.coviro.2021.04.009
|
| 26 |
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Osamu Yoshida, Yoichi Hiasa. Cellular and Molecular Mechanisms Underlying Scope and Limitation of Ongoing and Innovative Therapies for Treating Chronic Hepatitis B. Livers 2022; 2(1): 1 doi: 10.3390/livers2010001
|
| 27 |
Lena Allweiss, Maura Dandri. The Role of cccDNA in HBV Maintenance. Viruses 2017; 9(6): 156 doi: 10.3390/v9060156
|
| 28 |
Gang Wang, Zhi Chen, Jian Wu. HBV Genomic Integration and Hepatocellular Carcinoma. Advanced Gut & Microbiome Research 2022; 2022: 1 doi: 10.1155/2022/2140886
|
| 29 |
Katrin Busch, Robert Thimme. Natural history of chronic hepatitis B virus infection. Medical Microbiology and Immunology 2015; 204(1): 5 doi: 10.1007/s00430-014-0369-7
|
| 30 |
Ahmed Diab, Adrien Foca, Fabien Zoulim, David Durantel, Ourania Andrisani. The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals. Antiviral Research 2018; 149: 211 doi: 10.1016/j.antiviral.2017.11.015
|
| 31 |
Martin F. Jarrold. Applications of Charge Detection Mass Spectrometry in Molecular Biology and Biotechnology. Chemical Reviews 2022; 122(8): 7415 doi: 10.1021/acs.chemrev.1c00377
|
| 32 |
Christine Kim, Lauren F. Barnes, Christopher J. Schlicksup, Angela J. Patterson, Brian Bothner, Martin F. Jarrold, Che-Yen Joseph Wang, Adam Zlotnick, J.-H. James Ou. Core Protein-Directed Antivirals and Importin β Can Synergistically Disrupt Hepatitis B Virus Capsids. Journal of Virology 2022; 96(2) doi: 10.1128/JVI.01395-21
|
| 33 |
Samuel Hofmann, Verena Plank, Peter Groitl, Nathalie Skvorc, Katharina Hofmann, Julius Luther, Chunkyu Ko, Peter Zimmerman, Volker Bruss, Daniela Stadler, Arnaud Carpentier, Shahinda Rezk, Michael Nassal, Ulrike Protzer, Sabrina Schreiner, Peter Pelka. SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA. Microbiology Spectrum 2023; 11(3) doi: 10.1128/spectrum.00446-23
|
| 34 |
Daniel Puntener, Urs F. Greber. DNA-tumor virus entry—From plasma membrane to the nucleus. Seminars in Cell & Developmental Biology 2009; 20(5): 631 doi: 10.1016/j.semcdb.2009.03.014
|
| 35 |
B. Serruys, F. Van Houtte, A. Farhoudi-Moghadam, G. Leroux-Roels, P. Vanlandschoot. Production, characterization and in vitro testing of HBcAg-specific VHH intrabodies. Journal of General Virology 2010; 91(3): 643 doi: 10.1099/vir.0.016063-0
|
| 36 |
Laura J. Lester, Suneal K. Agarwal. Sexually Transmitted Infections and Sexually Transmitted Diseases. 2011; : 553 doi: 10.1007/978-3-642-14663-3_42
|
| 37 |
Haitao Guo, Dong Jiang, Tianlun Zhou, Andrea Cuconati, Timothy M. Block, Ju-Tao Guo. Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus: an Intermediate of Covalently Closed Circular DNA Formation. Journal of Virology 2007; 81(22): 12472 doi: 10.1128/JVI.01123-07
|
| 38 |
Camille Sureau. Hepatitis B Virus in Human Diseases. Molecular and Translational Medicine 2016; : 147 doi: 10.1007/978-3-319-22330-8_7
|
| 39 |
Tarik Asselah, Dimitri Loureiro, Nathalie Boyer, Abdellah Mansouri. Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure. The Lancet Gastroenterology & Hepatology 2019; 4(11): 883 doi: 10.1016/S2468-1253(19)30190-6
|
| 40 |
|
| 41 |
Abdullah Ely, Prashika Singh, Tiffany S. Smith, Patrick Arbuthnot. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection. Advanced Drug Delivery Reviews 2021; 168: 134 doi: 10.1016/j.addr.2020.05.010
|
| 42 |
Jasmine Samal, Manish Kandpal, Perumal Vivekanandan. Molecular Mechanisms Underlying Occult Hepatitis B Virus Infection. Clinical Microbiology Reviews 2012; 25(1): 142 doi: 10.1128/CMR.00018-11
|
| 43 |
Xian Hao, Xin Shang, Jiazhen Wu, Yuping Shan, Mingjun Cai, Junguang Jiang, Zhong Huang, Zhiyong Tang, Hongda Wang. Single‐Particle Tracking of Hepatitis B Virus‐like Vesicle Entry into Cells. Small 2011; 7(9): 1212 doi: 10.1002/smll.201002020
|
| 44 |
Christian Königer, Ida Wingert, Moritz Marsmann, Christine Rösler, Jürgen Beck, Michael Nassal. Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses. Proceedings of the National Academy of Sciences 2014; 111(40) doi: 10.1073/pnas.1409986111
|
| 45 |
William S. Mason, Sam Litwin, Allison R. Jilbert. Immune selection during chronic hepadnavirus infection. Hepatology International 2008; 2(1): 3 doi: 10.1007/s12072-007-9024-3
|
| 46 |
Stephan Urban, Andreas Schulze, Maura Dandri, Joerg Petersen. The replication cycle of hepatitis B virus. Journal of Hepatology 2010; 52(2): 282 doi: 10.1016/j.jhep.2009.10.031
|
| 47 |
Michael Nassal, Immanuel Leifer, Ida Wingert, Kai Dallmeier, Simone Prinz, Jolanta Vorreiter. A Structural Model for Duck Hepatitis B Virus Core Protein Derived by Extensive Mutagenesis. Journal of Virology 2007; 81(23): 13218 doi: 10.1128/JVI.00846-07
|
| 48 |
Nikta Fay, Nelly Panté. Nuclear entry of DNA viruses. Frontiers in Microbiology 2015; 6 doi: 10.3389/fmicb.2015.00467
|
| 49 |
Nuruddin Unchwaniwala, Nathan M. Sherer, Daniel D. Loeb, R. M. Sandri-Goldin. Hepatitis B Virus Polymerase Localizes to the Mitochondria, and Its Terminal Protein Domain Contains the Mitochondrial Targeting Signal. Journal of Virology 2016; 90(19): 8705 doi: 10.1128/JVI.01229-16
|
| 50 |
Christine Kim, Christopher J. Schlicksup, Carolina Pérez-Segura, Jodi A. Hadden-Perilla, Joseph Che-Yen Wang, Adam Zlotnick. Structure of the Hepatitis B virus capsid quasi-6-fold with a trapped C-terminal domain reveals capsid movements associated with domain exit. Journal of Biological Chemistry 2023; 299(9): 105104 doi: 10.1016/j.jbc.2023.105104
|
| 51 |
Yilin Li, Yishuang Sun, Fuyun Sun, Rong Hua, Chenlin Li, Lang Chen, Deyin Guo, Jingfang Mu. Mechanisms and Effects on HBV Replication of the Interaction between HBV Core Protein and Cellular Filamin B. Virologica Sinica 2018; 33(2): 162 doi: 10.1007/s12250-018-0023-4
|
| 52 |
Mary S. Dhason, Joseph C.-Y. Wang, Michael F. Hagan, Adam Zlotnick. Differential assembly of Hepatitis B Virus core protein on single- and double-stranded nucleic acid suggest the dsDNA-filled core is spring-loaded. Virology 2012; 430(1): 20 doi: 10.1016/j.virol.2012.04.012
|
| 53 |
Valentina Sirri, Silvio Urcuqui-Inchima, Pascal Roussel, Danièle Hernandez-Verdun. Nucleolus: the fascinating nuclear body. Histochemistry and Cell Biology 2008; 129(1): 13 doi: 10.1007/s00418-007-0359-6
|
| 54 |
Bo Liu, Xin Wen, Canhua Huang, Yuquan Wei. Unraveling the complexity of hepatitis B virus: From molecular understanding to therapeutic strategy in 50 years. The International Journal of Biochemistry & Cell Biology 2013; 45(9): 1987 doi: 10.1016/j.biocel.2013.06.017
|
| 55 |
Angela Patterson, Zhongchao Zhao, Elizabeth Waymire, Adam Zlotnick, Brian Bothner. Dynamics of Hepatitis B Virus Capsid Protein Dimer Regulate Assembly through an Allosteric Network. ACS Chemical Biology 2020; 15(8): 2273 doi: 10.1021/acschembio.0c00481
|
| 56 |
Michael Nassal. New insights into HBV replication: new opportunities for improved therapies. Future Virology 2009; 4(1): 55 doi: 10.2217/17460794.4.1.55
|
| 57 |
Zhongchao Zhao, Joseph Che-Yen Wang, Giovanni Gonzalez-Gutierrez, Balasubramanian Venkatakrishnan, Roi Asor, Daniel Khaykelson, Uri Raviv, Adam Zlotnick, J.-H. James Ou. Structural Differences between the Woodchuck Hepatitis Virus Core Protein in the Dimer and Capsid States Are Consistent with Entropic and Conformational Regulation of Assembly. Journal of Virology 2019; 93(14) doi: 10.1128/JVI.00141-19
|
| 58 |
Adam Zlotnick, Balasubramanian Venkatakrishnan, Zhenning Tan, Eric Lewellyn, William Turner, Samson Francis. Core protein: A pleiotropic keystone in the HBV lifecycle. Antiviral Research 2015; 121: 82 doi: 10.1016/j.antiviral.2015.06.020
|
| 59 |
Peter Vanlandschoot, Catelijne Stortelers, Els Beirnaert, Lorena Itatí Ibañez, Bert Schepens, Erik Depla, Xavier Saelens. Nanobodies®: New ammunition to battle viruses. Antiviral Research 2011; 92(3): 389 doi: 10.1016/j.antiviral.2011.09.002
|
| 60 |
Jiradej Makjaroen, Poorichaya Somparn, Kenneth Hodge, Witthaya Poomipak, Nattiya Hirankarn, Trairak Pisitkun. Comprehensive Proteomics Identification of IFN-λ3-regulated Antiviral Proteins in HBV-transfected Cells. Molecular & Cellular Proteomics 2018; 17(11): 2197 doi: 10.1074/mcp.RA118.000735
|
| 61 |
Wen Siang Tan, Kok Lian Ho. Phage display creates innovative applications to combat hepatitis B virus. World Journal of Gastroenterology 2014; 20(33): 11650-11670 doi: 10.3748/wjg.v20.i33.11650
|
| 62 |
Hung-Chih Yang, Shiou-Hwei Yeh, Pei-Jer Chen, Ding-Shinn Chen. Viruses and Human Cancer. 2014; : 113 doi: 10.1007/978-1-4939-0870-7_6
|
| 63 |
Zahra Zahid Piracha, Hyeonjoong Kwon, Umar Saeed, Jumi Kim, Jaesung Jung, Yong-Joon Chwae, Sun Park, Ho-Joon Shin, Kyongmin Kim, J.-H. James Ou. Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3β/β-Catenin Signaling Pathway. Journal of Virology 2018; 92(21) doi: 10.1128/JVI.00955-18
|
| 64 |
Sarah Cohen, Shelly Au, Nelly Panté. How viruses access the nucleus. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011; 1813(9): 1634 doi: 10.1016/j.bbamcr.2010.12.009
|
| 65 |
Hong Tang, Mei-Fang Han, Ji-Ming Zhang. Acute Exacerbation of Chronic Hepatitis B. 2019; : 119 doi: 10.1007/978-94-024-1606-0_3
|
| 66 |
|
| 67 |
Raimundas Razanskas, Kestutis Sasnauskas. Interaction of hepatitis B virus core protein with human GIPC1. Archives of Virology 2010; 155(2): 247 doi: 10.1007/s00705-009-0561-z
|
| 68 |
Qiao He, Wanyu Li, Jihua Ren, Yecai Huang, Ying Huang, Qin Hu, Juan Chen, Weixian Chen. ZEB2 inhibits HBV transcription and replication by targeting its core promoter. Oncotarget 2016; 7(13): 16003 doi: 10.18632/oncotarget.7435
|
| 69 |
Alexandra Alexopoulou, Larisa Vasilieva, Peter Karayiannis. New Approaches to the Treatment of Chronic Hepatitis B. Journal of Clinical Medicine 2020; 9(10): 3187 doi: 10.3390/jcm9103187
|
| 70 |
Joao M. Serigado, Manhal Izzy, Harmit Kalia. Novel therapies and potential therapeutic targets in the management of chronic hepatitis B. European Journal of Gastroenterology & Hepatology 2017; 29(9): 987 doi: 10.1097/MEG.0000000000000911
|
| 71 |
Hua Yang, Jiayin Mo, Qi Xiang, Peiyi Zhao, Yunting Song, Ge Yang, Kailang Wu, Yingle Liu, Weiyong Liu, Jianguo Wu. SOX2 Represses Hepatitis B Virus Replication by Binding to the Viral EnhII/Cp and Inhibiting the Promoter Activation. Viruses 2020; 12(3): 273 doi: 10.3390/v12030273
|